Stock Screener App

무료 -

설치하다

3.53

1.73% 0.06

Atea Pharmaceuticals Inc (AVIR)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Atea Pharmaceuticals Inc (AVIR) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	-	-	-
Operating Expenses	49.89% 69.81	46.57	40.78	35.23	41.57
Depreciation and Amortization	0.00% 0.104	0.104	0.104	0.104	0.104
Operating Income/Loss	49.89% -69.81	-46.57	-40.78	-35.23	-41.57
Income/Loss From Continuing Operations Before Tax	62.15% -62.94	-38.81	-32.92	-27.93	-35.27
Income Tax Expense/Benefit	33.81% 0.231	0.349	0.221	0.251	0.197
Income/Loss From Continuing Operations After Tax	61.29% -63.17	-39.16	-33.14	-28.18	-35.47
Net Income/Loss	61.29% -63.17	-39.16	-33.14	-28.18	-35.47
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	544.03K% 83.92	0.0154	83.40	83.40	83.33
Diluted Average Shares	544.03K% 83.92	0.0154	83.40	83.40	83.33
Basic Earnings Per Share	59.57% -0.75	-0.47	-0.40	-0.34	-0.43
Diluted Earnings Per Share	59.57% -0.75	-0.47	-0.40	-0.34	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$78.04

3.24%

RPRX

$37.88

2.07%

INSM

$111.24

2.35%

SMMT

$29.32

8.31%

BNTX

$110.03

2.51%

ONC

$304.30

1.77%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개